Mylan Beats Most Claims In Investor Suit Over W.Va. Plant
A Pennsylvania federal judge cut down a proposed stockholder class action against pharmaceutical company Mylan NV that alleges it artificially increased its stock price by manipulating quality control tests at a...To view the full article, register now.
Already a subscriber? Click here to view full article